Avenue Therapeutics, Inc. (ATXI) vs Vincerx Pharma, Inc. (VINC)
Avenue Therapeutics, Inc. and Vincerx Pharma, Inc. are both Biotechnology companies. Avenue Therapeutics, Inc. is the larger, with a market value of $680.0K against $250.0K — 2.7× the size. Across the 8 metrics below, Avenue Therapeutics, Inc. leads on 5 and Vincerx Pharma, Inc. on 3.
Valuation
Profitability
| Metric | ATXI | VINC | Biotechnology median |
|---|---|---|---|
| Gross margin | — | 0.00% | 65.16% |
| Operating margin | 0.00% | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% | 0.00% |
| Free cash flow margin | 0.00% | 0.00% | 0.00% |
| Return on equity | (163.30%) | (3,136.43%) | (57.72%) |
| Return on assets | (90.50%) | (287.21%) | (49.22%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack